Tomi Toler

Medicine & Life Sciences

1. Down Syndrome 100%
2. Counselors 74%
3. Nasodigitoacoustic syndrome 74%
4. Exome 64%
5. Regulatory Factor X Transcription Factors 62%
6. Brain Diseases 60%
7. Intellectual Disability 60%
8. Phenotype 58%
9. Juvenile polyposis syndrome 55%
10. Methyl CpG Binding Domain 54%
11. Medical Genetics 53%
12. Coenzyme Q10 Deficiency 53%
13. Kabuki syndrome 53%
14. oligomycin sensitivity-conferring protein 51%
15. Registries 50%
16. Mandibulofacial Dysostosis 50%
17. Neurodevelopmental Disorders 50%
18. Glypicans 47%
19. Thoracic Diseases 46%
20. Autistic Disorder 42%
21. Juvenile Polyposis with Hereditary Hemorrhagic Telangiectasia 41%
22. Aortic Diseases 39%
23. Neurofibromatosis 1 39%
24. Medicine 39%
25. Practice Guidelines 37%
26. Neural Crest 37%
27. X Chromosome 36%
28. Evidence-Based Practice 35%
29. Celiac Disease 35%
30. Genetic Counseling 35%
31. Giant Cells 34%
32. Fibroma 34%
33. Attention Deficit Disorder with Hyperactivity 32%
34. Whole Exome Sequencing 32%
35. Psychopathology 31%
36. Genes 30%
37. Mutation 30%
38. SNARE Proteins 28%
39. Carrier Proteins 27%
40. Risk Assessment 26%
41. Autism Spectrum Disorder 26%
42. Thyroid Gland 26%
43. beta-resorcylic acid 26%
44. Heart Diseases 25%
45. Hyperlactatemia 25%
46. Guidelines 23%
47. Dissecting Aneurysm 22%
48. Hyperammonemia 21%
49. Growth 21%
50. Seizures 21%